UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis with the Synthetic Immunomodulator Linomide (Quinoline-3-Carboxamide)

Proceedings of the National Academy of Sciences - PNAS, 1993-07, Vol.90 (14), p.6400-6404

1993

Volltextzugriff (PDF)

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide

Annals of neurology, 1993-11, Vol.34 (5), p.654-660

1993

Volltextzugriff (PDF)

Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation

Multiple sclerosis, 1999-02, Vol.5 (1), p.17-21

1999

Volltextzugriff (PDF)

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation

The Journal of clinical investigation, 1993-08, Vol.92 (2), p.765-772

1993

Volltextzugriff (PDF)

Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice

Experimental hematology, 1995-03, Vol.23 (3), p.196

1995

Volltextzugriff (PDF)

Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)

Clinical and experimental immunology, 1995-04, Vol.100 (1), p.111-117

1995

Volltextzugriff (PDF)

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation

Journal of neuroimmunology, 1992-08, Vol.39 (3), p.201-210

1992

Volltextzugriff (PDF)

Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT)

Leukemia, 1992-11, Vol.6, p.164-166

1992

Volltextzugriff (PDF)

Correlation between Enhancement of Graft-versus-leukemia Effects Following Allogeneic Bone Marrow Transplantation by RIL-2 and Increased Frequency of Cytotoxic T-lymphocyte Precursors in Murine Myeloid Leukemia

Cytokines, cellular & molecular therapy., 2000-09, Vol.6 (3), p.141-147

2000

Volltextzugriff (PDF)

Investigations on the role of inflammatory and anti-inflammatory agents on the treatment of murine B cell leukemia by recombinant human interleukin-2

Experimental hematology, 1993, Vol.21 (1), p.93-97

1993

Volltextzugriff (PDF)

Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders

Transplantation proceedings, 1993-02, Vol.25 (1), p.1274-1275

1993

Volltextzugriff (PDF)

Prevention and treatment of relapse by bone marrow transplantation

Bone marrow transplantation (Basingstoke), 1993, Vol.12 Suppl 3, p.S54-S56

1993

Volltextzugriff (PDF)

Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: Comparison of T-cell and IL-2 activated killer (LAK) cell–mediated adoptive immunotherapy in murine models

Experimental hematology, 1999-03, Vol.27 (3), p.461-469

1999

Volltextzugriff (PDF)

Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens

The Journal of immunology (1950), 1993-11, Vol.151 (9), p.4803-4810

1993

Volltextzugriff (PDF)

Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation

Multiple sclerosis, 1999-02, Vol.5 (1), p.017-021

1999

Volltextzugriff (PDF)

Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in mice

Leukemia research, 1996-11, Vol.20 (11), p.941-946

1996

Volltextzugriff (PDF)

Immunomodulation of autoimmunity by linomide

Israel journal of medical sciences, 1995-01, Vol.31 (1), p.38

1995

Volltextzugriff (PDF)

Long-term antigen-specific tolerance in EAE, by syngeneic bone marrow transplantation

Journal of neuroimmunology, 1998-09, Vol.90 (1), p.57-57

1998

Volltextzugriff (PDF)

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE) : treatment and induction of tolerance, with high dose cyclphosphamide followed by syngeneic bone marrow transplantation

Journal of neuroimmunology, 1992, Vol.39 (3), p.201-210

1992

Volltextzugriff (PDF)

Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation

Baillière's clinical haematology, 1991-07, Vol.4 (3), p.715-725

1991

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Treatment of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis with the Synthetic Immunomodulator Linomide (Quinoline-3-Carboxamide)

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide

Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation

Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice

Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation

Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT)

Correlation between Enhancement of Graft-versus-leukemia Effects Following Allogeneic Bone Marrow Transplantation by RIL-2 and Increased Frequency of Cytotoxic T-lymphocyte Precursors in Murine Myeloid Leukemia

Investigations on the role of inflammatory and anti-inflammatory agents on the treatment of murine B cell leukemia by recombinant human interleukin-2

Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders

Prevention and treatment of relapse by bone marrow transplantation

Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: Comparison of T-cell and IL-2 activated killer (LAK) cell–mediated adoptive immunotherapy in murine models

Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens

Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation

Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in mice

Immunomodulation of autoimmunity by linomide

Long-term antigen-specific tolerance in EAE, by syngeneic bone marrow transplantation

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE) : treatment and induction of tolerance, with high dose cyclphosphamide followed by syngeneic bone marrow transplantation

Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation

Suchergebnisse filtern